Works matching AU Tamura, Atsuhisa


Results: 21
    1
    2
    3

    Lung cancer in patients with chronic pyothorax.

    Published in:
    Respirology, 2008, v. 13, n. 4, p. 585, doi. 10.1111/j.1440-1843.2008.01281.x
    By:
    • Tamura, Atsuhisa;
    • Hebisawa, Akira;
    • Iuchi, Keiji;
    • Maeda, Hajime;
    • Fukai, Shimao;
    • Komatsu, Hikotaro;
    • Kawahara, Masaaki
    Publication type:
    Article
    4

    Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

    Published in:
    BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03212-5
    By:
    • Taniguchi, Yoshihiko;
    • Tamiya, Akihiro;
    • Osuga, Mitsuo;
    • Harada, Daijiro;
    • Isa, Shun-ichi;
    • Nakamura, Keiichi;
    • Mizumori, Yasuyuki;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    5
    6

    High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.

    Published in:
    Medical Mycology, 2021, v. 59, n. 4, p. 327, doi. 10.1093/mmy/myaa052
    By:
    • Takeda, Keita;
    • Suzuki, Junko;
    • Watanabe, Akira;
    • Arai, Teppei;
    • Koiwa, Tomohiro;
    • Shinfuku, Kyota;
    • Narumoto, Osamu;
    • Kawashima, Masahiro;
    • Fukami, Takeshi;
    • Tamura, Atsuhisa;
    • Nagai, Hideaki;
    • Matsui, Hirotoshi;
    • Kamei, Katsuhiko
    Publication type:
    Article
    7
    8
    9

    Circulating Tumour DNA in Patients With EGFR‐Mutated Non‐Small‐Cell Lung Cancer and Early Disease Progression After First‐Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70861
    By:
    • Tamiya, Akihiro;
    • Mizumori, Yasuyuki;
    • Osuga, Mitsuo;
    • Isa, Shun‐ichi;
    • Taniguchi, Yoshihiko;
    • Nakamura, Keiichi;
    • Harada, Daijiro;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 17, p. 1597, doi. 10.1111/1759-7714.14904
    By:
    • Shimokawa, Mototsugu;
    • Kanazu, Masaki;
    • Saito, Ryusei;
    • Mori, Masahide;
    • Tamura, Atsuhisa;
    • Okano, Yoshio;
    • Fujita, Yuka;
    • Endo, Takeo;
    • Motegi, Mitsuru;
    • Takata, Shohei;
    • Kita, Toshiyuki;
    • Sukoh, Noriaki;
    • Mizuki, Fumitaka;
    • Takenoyama, Mitsuhiro;
    • Atagi, Shinji
    Publication type:
    Article
    17

    A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring EGFR mutations (JMTO LC12‐01).

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 12, p. 1827, doi. 10.1111/1759-7714.14465
    By:
    • Asami, Kazuhiro;
    • Ando, Masahiko;
    • Nishimura, Takashi;
    • Yokoi, Takashi;
    • Tamura, Atsuhisa;
    • Minato, Koichi;
    • Mori, Masahide;
    • Ogushi, Fumitaka;
    • Yamamoto, Akiyoshi;
    • Yoshioka, Hiroshige;
    • Kawahara, Masaaki;
    • Atagi, Shinji
    Publication type:
    Article
    18
    19
    20
    21